Both are antioxidants. Both have RCT evidence for skin outcomes. But they work through different mechanisms, target different problems, and the evidence for each is stronger in different areas.
Astaxanthin and vitamin C are both positioned as antioxidants for skin health, and both have genuine clinical evidence. But comparing them as if they were interchangeable is a mistake. They work through different mechanisms, they are absorbed differently, and the evidence for each is stronger in different domains. This review maps the actual evidence for each and identifies where they complement rather than compete.
Vitamin C (ascorbic acid) is a water-soluble antioxidant with a specific and well-characterised role in collagen biosynthesis. It is an essential cofactor for prolyl hydroxylase and lysyl hydroxylase — the enzymes that hydroxylate proline and lysine residues in procollagen, stabilising the triple helix and enabling secretion. Without adequate vitamin C, collagen synthesis fails. This is not a marginal effect; it is the mechanism of scurvy. Vitamin C also acts as a direct antioxidant in the aqueous phase of cells and plasma, and inhibits melanin production by reducing dopaquinone.
Astaxanthin is a xanthophyll carotenoid — a fat-soluble pigment produced by microalgae (primarily Haematococcus pluvialis). Its antioxidant mechanism is structurally different: astaxanthin spans the full thickness of cell membranes, with its polar end groups on either side, allowing it to quench free radicals in both the aqueous and lipid phases simultaneously. This amphipathic structure makes it unusually effective at protecting cell membranes from oxidative damage. It is 40 times more potent than beta-carotene and 100–1,000 times more potent than tocopherol (vitamin E) in certain antioxidant assays.
A 2021 systematic review and meta-analysis (Zhou et al., Nutrients, n=162 astaxanthin, 131 placebo) pooled data from multiple RCTs of oral astaxanthin supplementation. The results: significant improvement in skin moisture content (standardised mean difference 0.53, p=0.03) and skin elasticity (SMD 0.77, p=0.009). Notably, wrinkle depth did not reach statistical significance (SMD -0.26). The effective dose across trials was 2–12 mg/day; most trials used 4–6 mg.
A 2018 trial by Ito et al. (n=30) specifically examined UV-induced skin deterioration and found that 4 mg/day of oral astaxanthin improved moisture maintenance and reduced transepidermal water loss after UV exposure. This is consistent with the proposed mechanism: astaxanthin protects cell membranes from UV-induced oxidative damage, reducing the downstream inflammatory cascade.
The vitamin C evidence is split between oral and topical routes, and the two are not equivalent. Topical vitamin C has strong evidence: a 10% topical formulation reduced UVB-induced erythema by 52% and apoptotic sunburn cell formation by 40–60% in laboratory studies. A 25% topical formulation significantly decreased melasma pigmentation after 16 weeks. Topical vitamin C is one of the few cosmetic ingredients with genuine dermatology-grade evidence.
Oral vitamin C is more complicated. The evidence for oral supplementation specifically improving skin outcomes in non-deficient individuals is weaker than for topical application. However, a 2024 RCT (Žmitek et al., n=87) combining 5 g hydrolysed collagen with 80 mg vitamin C showed enhanced dermis density, improved skin texture, and reduced wrinkle severity — suggesting that oral vitamin C may be most effective as a cofactor for collagen synthesis when combined with collagen peptides.
Astaxanthin: proven for moisture and elasticity, not wrinkle depth. Vitamin C: proven for collagen synthesis and topical photoprotection. These are complementary, not competing, effects.
Vitaei verdict
These are not competitors — they address different aspects of skin ageing through different mechanisms. The rational approach is to use both: astaxanthin (4–6 mg/day oral) for membrane-level antioxidant protection and UV resilience; vitamin C (topical 10–20%, or oral as a collagen synthesis cofactor) for collagen support and pigmentation. Choosing one over the other misses the point.
Skin ageing at the cellular level: the 12 hallmarks applied to skin
The same nine — now twelve — hallmarks that drive systemic ageing play out in skin with unusual visibility. Understanding them explains why some interventions work and most don't.
The UV damage cascade: how sun exposure ages skin at the molecular level
Photoaging accounts for 80% of extrinsic skin ageing. Understanding the molecular cascade — from photon to wrinkle — explains why sunscreen is the most evidence-supported anti-ageing intervention available.
The collagen synthesis pathway: why vitamin C is non-negotiable
Collagen is the most abundant protein in the human body. Vitamin C is required to make it. This is not a supplement claim — it is biochemistry. Here is the pathway, and what happens when it fails.